Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

SZSE:002223 Stock Report

Market Cap: CN¥35.7b

Jiangsu Yuyue Medical Equipment & Supply Valuation

Is 002223 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002223 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002223 (CN¥35.63) is trading above our estimate of fair value (CN¥11.56)

Significantly Below Fair Value: 002223 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002223?

Key metric: As 002223 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002223. This is calculated by dividing 002223's market cap by their current earnings.
What is 002223's PE Ratio?
PE Ratio20.6x
EarningsCN¥1.74b
Market CapCN¥35.70b

Price to Earnings Ratio vs Peers

How does 002223's PE Ratio compare to its peers?

The above table shows the PE ratio for 002223 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average43.2x
300529 Jafron BiomedicalLtd
29.5x26.1%CN¥23.7b
688617 APT Medical
49.6x29.3%CN¥32.7b
300003 Lepu Medical Technology (Beijing)
31.4x42.4%CN¥22.2b
300633 SonoScape Medical
62.4x54.7%CN¥15.1b
002223 Jiangsu Yuyue Medical Equipment & Supply
20.6x18.7%CN¥35.7b

Price-To-Earnings vs Peers: 002223 is good value based on its Price-To-Earnings Ratio (20.6x) compared to the peer average (43.2x).


Price to Earnings Ratio vs Industry

How does 002223's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
002223 20.6xIndustry Avg. 35.2xNo. of Companies19PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 002223 is good value based on its Price-To-Earnings Ratio (20.6x) compared to the CN Medical Equipment industry average (35.2x).


Price to Earnings Ratio vs Fair Ratio

What is 002223's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002223 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.6x
Fair PE Ratio26.5x

Price-To-Earnings vs Fair Ratio: 002223 is good value based on its Price-To-Earnings Ratio (20.6x) compared to the estimated Fair Price-To-Earnings Ratio (26.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 002223 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥35.63
CN¥45.99
+29.1%
5.1%CN¥49.69CN¥44.00n/a4
Nov ’25CN¥34.86
CN¥46.49
+33.4%
4.4%CN¥49.69CN¥44.00n/a4
Oct ’25CN¥38.28
CN¥46.87
+22.4%
4.5%CN¥49.69CN¥44.00n/a4
Sep ’25CN¥33.08
CN¥46.87
+41.7%
4.5%CN¥49.69CN¥44.00n/a4
Aug ’25CN¥35.11
CN¥47.39
+35.0%
5.3%CN¥49.85CN¥44.00n/a4
Jul ’25CN¥37.75
CN¥47.39
+25.5%
5.3%CN¥49.85CN¥44.00n/a4
Jun ’25CN¥38.93
CN¥46.62
+19.7%
5.2%CN¥49.85CN¥44.00n/a3
May ’25CN¥38.65
CN¥46.79
+21.1%
8.3%CN¥51.30CN¥42.00n/a4
Apr ’25CN¥34.23
CN¥44.45
+29.9%
9.9%CN¥51.30CN¥39.50n/a4
Mar ’25CN¥35.75
CN¥44.45
+24.3%
9.9%CN¥51.30CN¥39.50n/a4
Feb ’25CN¥31.96
CN¥44.45
+39.1%
9.9%CN¥51.30CN¥39.50n/a4
Jan ’25CN¥34.58
CN¥44.45
+28.5%
9.9%CN¥51.30CN¥39.50n/a4
Dec ’24CN¥33.79
CN¥44.45
+31.6%
9.9%CN¥51.30CN¥39.50n/a4
Nov ’24CN¥33.21
CN¥44.45
+33.9%
9.9%CN¥51.30CN¥39.50CN¥34.864
Oct ’24CN¥34.44
CN¥42.69
+24.0%
6.9%CN¥46.57CN¥39.50CN¥38.283
Sep ’24CN¥33.50
CN¥41.00
+22.4%
2.6%CN¥42.00CN¥39.50CN¥33.083
Aug ’24CN¥33.77
CN¥40.73
+20.6%
2.5%CN¥42.00CN¥39.50CN¥35.113
Jul ’24CN¥35.99
CN¥41.70
+15.9%
1.7%CN¥42.40CN¥40.70CN¥37.753
Jun ’24CN¥33.21
CN¥41.70
+25.6%
1.7%CN¥42.40CN¥40.70CN¥38.933
May ’24CN¥31.56
CN¥39.55
+25.3%
6.9%CN¥42.40CN¥35.10CN¥38.654
Apr ’24CN¥31.84
CN¥39.07
+22.7%
6.7%CN¥42.40CN¥35.10CN¥34.234
Mar ’24CN¥31.58
CN¥39.07
+23.7%
6.7%CN¥42.40CN¥35.10CN¥35.754
Feb ’24CN¥30.85
CN¥38.76
+25.6%
7.7%CN¥42.40CN¥35.10CN¥31.963
Jan ’24CN¥31.86
CN¥38.76
+21.6%
7.7%CN¥42.40CN¥35.10CN¥34.583
Dec ’23CN¥34.85
CN¥36.94
+6.0%
5.0%CN¥38.77CN¥35.10CN¥33.792
Nov ’23CN¥34.59
CN¥34.19
-1.2%
12.2%CN¥38.77CN¥28.70CN¥33.213

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies